Andrew Jay Rong, MD
Ophthalmology · Fort Lauderdale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 32
Offices
32 locations · University of Miami · 2,346 clinicians in this group
Hospitals listed: Univ of Miami Hospital and Clinics-Sylvester Compr. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rong’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Florida ME135518Medical Doctor · since 2018 · expires 2028-01-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- Ophthalmology
Education
- UC Davis School of Medicine2010–2014
What else the board holds
Hospitals they may admit to
Where the clinician told their state board they may admit and treat patients.
- University of Miami Mller School of Medicine · FL
Original Medicare doctor bills
$117,466
Medicare paid this office $117,466 for 362 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of excessive skin and fat of upper eyelid | 47 | $29,378 | $625 |
| Short return visit (20+ min) | 111 | $7,175 | $51 |
| Return visit (30+ min) | 70 | $6,112 | $87 |
| Return visit (30+ min) | 64 | $5,228 | $73 |
| Short return visit (20+ min) | 67 | $4,953 | $70 |
See all 11 services
| Removal of excessive skin and fat of upper eyelid | 47 | $29,378 | $625 |
| Short return visit (20+ min) | 111 | $7,175 | $51 |
| Return visit (30+ min) | 70 | $6,112 | $87 |
| Return visit (30+ min) | 64 | $5,228 | $73 |
| Short return visit (20+ min) | 67 | $4,953 | $70 |
| New patient visit (45+ min) | 15 | $1,563 | $104 |
| Removal of growth of eyelid | 14 | $1,469 | $105 |
| Exam of visual field with limited testing | 54 | $1,194 | $21 |
| Photography of content of eyes | 58 | $981 | $17 |
| Exam of visual field with limited testing | 43 | $503 | $11 |
| Photography of content of eyes | 49 | $123 | $2 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 12 | More than 66% of doctors who do this |
Who their Medicare patients are
362 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 12% · Women 63% · Also on Medicaid 18% · Health risk score 1.15. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 74% · Coronary heart disease 37% · Diabetes 29% · Chronic kidney disease 20% · Depression 20% · Cancer 16% · Atrial fibrillation 14% · Stroke 11% · COPD 10% · Heart failure 9% · Dementia 6%.
The office billed $580,657, Medicare allowed $154,236 and paid $117,466; for 1,452 services of 82 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 362 | 1,452 | 75 | 1.15 | $580,657 | $117,466 |
| 2023 | 369 | 1,447 | 75 | 1.38 | $552,517 | $117,119 |
| 2022 | 388 | 1,445 | 74 | 1.26 | $655,129 | $136,808 |
| 2021 | 378 | 966 | 75 | 1.35 | $555,814 | $122,204 |
| 2020 | 172 | 487 | 74 | 1.44 | $169,420 | $36,996 |
| 2019 | 142 | 164 | 72 | 1.68 | $44,207 | $8,003 |
| 2018 | 101 | 104 | 70 | 1.87 | $34,505 | $7,606 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Removal of excessive skin and fat of upper eyelid | 47 | $30,345 | $646 |
| Return visit (30+ min) | 69 | $6,434 | $88 |
| Return visit (30+ min) | 76 | $6,331 | $76 |
| Short return visit (20+ min) | 95 | $5,635 | $50 |
| Short return visit (20+ min) | 58 | $4,375 | $68 |
| Removal of growth of eyelid | 20 | $2,234 | $106 |
| New patient visit (45+ min) | 14 | $1,505 | $108 |
| Exam of visual field with limited testing | 48 | $959 | $20 |
| Emergency department visit with low level of medical decision making | 18 | $786 | $44 |
| Photography of content of eyes | 48 | $761 | $16 |
| Exam of visual field with limited testing | 48 | $553 | $11 |
| Photography of content of eyes | 53 | $138 | $2 |
2022: 13 services
| Removal of excessive skin and fat of upper eyelid | 49 | $33,696 | $688 |
| Return visit (30+ min) | 92 | $8,743 | $94 |
| Short return visit (20+ min) | 80 | $6,605 | $67 |
| Short return visit (20+ min) | 76 | $5,099 | $55 |
| Return visit (30+ min) | 63 | $4,905 | $74 |
| Reconstruction of eyelid margin | 11 | $3,984 | $362 |
| New patient visit (45+ min) | 14 | $1,485 | $106 |
| Exam of visual field with limited testing | 61 | $1,342 | $21 |
| New patient visit (45+ min) | 13 | $1,251 | $96 |
| Emergency department visit with low level of medical decision making | 24 | $1,118 | $47 |
| Photography of content of eyes | 62 | $1,047 | $17 |
| Exam of visual field with limited testing | 42 | $472 | $11 |
| Photography of content of eyes | 41 | $102 | $2 |
2021: 17 services
| Removal of excessive skin and fat of upper eyelid | 39 | $27,482 | $705 |
| Short return visit (20+ min) | 130 | $12,068 | $71 |
| Return visit (30+ min) | 64 | $6,549 | $99 |
| Reconstruction of eyelid margin | 14 | $5,498 | $393 |
| Short return visit (20+ min) | 78 | $5,095 | $55 |
| Return visit (30+ min) | 51 | $4,718 | $84 |
| New patient visit (45+ min) | 14 | $1,625 | $116 |
| Dilation of tear drainage opening | 13 | $1,419 | $101 |
| Exam of visual field with limited testing | 49 | $1,260 | $23 |
| Photography of content of eyes | 54 | $1,011 | $18 |
| Dilation of tear drainage opening | 12 | $977 | $81 |
| New patient visit (30+ min) | 12 | $798 | $66 |
| New patient visit (30+ min) | 11 | $748 | $68 |
| Emergency department visit with low level of medical decision making | 11 | $724 | $66 |
| Short return visit | 15 | $472 | $31 |
| Exam of visual field with limited testing | 35 | $469 | $13 |
| Photography of content of eyes | 44 | $125 | $3 |
2020: 8 services
| Established patient problem focused exam of visual system | 67 | $5,320 | $72 |
| Emergency department visit with low level of medical decision making | 27 | $1,526 | $57 |
| Established patient problem focused exam of visual system | 31 | $1,474 | $43 |
| Short return visit (20+ min) | 11 | $504 | $46 |
| Exam of visual field with limited testing | 17 | $407 | $24 |
| Photography of content of eyes | 22 | $397 | $18 |
| Exam of visual field with limited testing | 14 | $194 | $14 |
| Photography of content of eyes | 16 | $49 | $3 |
2019: 3 services
| Emergency department visit with low level of medical decision making | 83 | $3,575 | $43 |
| Exam of visual field with limited testing | 11 | $149 | $12 |
| Photography of content of eyes | 17 | $48 | $3 |
2018: 2 services
| New patient visit (30+ min) | 39 | $2,608 | $67 |
| Emergency department visit with low level of medical decision making | 38 | $2,088 | $55 |
Medicaid work
$857 in 2023
Medicaid paid $857 for 13 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 13 | $857 |
| 2023 | 13 | 1 | 13 | $857 |
| 2022 | 14 | 1 | 12 | $333 |
| 2019 | 30 | 1 | 15 | $864 |
See the largest Medicaid services in earlier years
2022
| Hospital outpatient clinic visit for assessment and management of a patient | 14 | $333 |
2019
| EMERGENCY DEPT VISIT LOW MDM | 30 | $864 |
Drugs they prescribed that Part D paid
$5,963
Pharmacies billed $5,963 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
417 generic and 24 brand-name prescriptions · $5,963 in drug cost · 23 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Erythromycin | 257 | $2,804 | $11 |
| Neomycin-Polymyxin-Dexameth | 54 | $654 | $12 |
| Prednisolone Acetate | 13 | $381 | $29 |
| Moxifloxacin | 13 | $270 | $21 |
| Methylprednisolone | 22 | $164 | $7 |
See all 7 drugs
| Erythromycin | 257 | $2,804 | $11 |
| Neomycin-Polymyxin-Dexameth | 54 | $654 | $12 |
| Prednisolone Acetate | 13 | $381 | $29 |
| Moxifloxacin | 13 | $270 | $21 |
| Methylprednisolone | 22 | $164 | $7 |
| Prednisone | 22 | $122 | $6 |
| Cephalexin | 11 | $87 | $8 |
Year by year
| 2024 | 441 | 251 | None | 5% | $5,963 |
| 2023 | 394 | 239 | None | 9% | $8,184 |
| 2022 | 479 | 258 | None | 18% | $532,873 |
| 2021 | 448 | 239 | None | 21% | $95,527 |
| 2020 | 223 | 130 | None | 21% | $6,663 |
| 2019 | 190 | 112 | 10% (18) | 18% | $5,878 |
| 2018 | 133 | 73 | None | 30% | $6,940 |
| 2017 | 244 | 94 | 0% (0) | 26% | $8,838 |
| 2016 | 190 | 93 | 0% (0) | None | $5,996 |
| 2015 | 111 | 49 | 0% (0) | None | $7,682 |
| 2014 | 17 | None | None | None | $296 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Erythromycin | 216 | $2,390 | $11 |
| Neomycin-Polymyxin-Dexameth | 72 | $1,000 | $14 |
| Prednisolone Acetate | 13 | $458 | $35 |
| Methylprednisolone | 15 | $157 | $10 |
| Polymyxin B Sul-Trimethoprim | 12 | $105 | $9 |
2022: 8 drugs
| Erythromycin | 214 | $2,281 | $11 |
| Neomycin-Polymyxin-Dexameth | 76 | $1,020 | $13 |
| Prednisolone Acetate | 22 | $828 | $38 |
| Dorzolamide-Timolol | 12 | $337 | $28 |
| Latanoprost | 13 | $299 | $23 |
| Prednisone | 23 | $183 | $8 |
| Polymyxin B Sul-Trimethoprim | 11 | $103 | $9 |
| Methylprednisolone | 16 | $98 | $6 |
2021: 6 drugs
| Xiidra | 12 | $6,919 | $577 |
| Erythromycin | 192 | $2,282 | $12 |
| Neomycin-Polymyxin-Dexameth | 86 | $1,247 | $14 |
| Olopatadine | 20 | $517 | $26 |
| Prednisolone Acetate | 14 | $502 | $36 |
| Moxifloxacin | 14 | $473 | $34 |
2020: 4 drugs
| Erythromycin | 77 | $913 | $12 |
| Prednisolone Acetate | 18 | $657 | $36 |
| Neomycin-Polymyxin-Dexameth | 25 | $401 | $16 |
| Prednisone | 15 | $120 | $8 |
2019: 3 drugs
| Neomycin-Polymyxin-Dexameth | 42 | $639 | $15 |
| Erythromycin | 29 | $357 | $12 |
| Bacitracin-Polymyxin | 12 | $227 | $19 |
2018: 4 drugs
| Prednisolone Acetate | 14 | $664 | $47 |
| Neomycin-Polymyxin-Dexameth | 17 | $213 | $13 |
| Erythromycin | 15 | $176 | $12 |
| Polymyxin B Sul-Trimethoprim | 11 | $111 | $10 |
2017: 6 drugs
| Prednisolone Acetate | 48 | $2,132 | $44 |
| Dorzolamide-Timolol | 35 | $839 | $24 |
| Latanoprost | 39 | $740 | $19 |
| Polymyxin B Sul-Trimethoprim | 24 | $219 | $9 |
| Neomycin-Polymyxin-Dexameth | 12 | $172 | $14 |
| Timolol Maleate | 20 | $162 | $8 |
2016: 5 drugs
| Prednisolone Acetate | 20 | $744 | $37 |
| Dorzolamide-Timolol | 33 | $533 | $16 |
| Latanoprost | 26 | $325 | $12 |
| Neomycin-Polymyxin-Dexameth | 20 | $287 | $14 |
| Polymyxin B Sul-Trimethoprim | 18 | $153 | $9 |
Money from drug and device companies
$236 in 2025
| 2025 | 5 | 5 | None | $236 |
| 2024 | 4 | 11 | $4,000 | $5,637 |
| 2023 | 4 | 15 | $4,800 | $6,320 |
| 2022 | 5 | 8 | None | $706 |
| 2021 | 3 | 6 | None | $494 |
| 2020 | 4 | 5 | None | $355 |
| 2019 | 8 | 12 | None | $1,100 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Axogen | None | $126 | 1 payment
|
| Ethicon US | Vistaseal | $43 | 1 payment
|
| Argenx US | Vyvgart Hytrulo | $27 | 1 payment
|
| Caris MPI | Mi Cancer Seek | $24 | 1 payment
|
| Amgen | Tepezza | $16 | 1 payment
|
See all 5 published payments
| Axogen | Meals · 2025-10-23 | None | $126 |
| Ethicon US | Meals · 2025-09-23 | Vistaseal | $43 |
| Caris MPI | Meals · 2025-08-12 | Mi Cancer Seek | $24 |
| Argenx US | Meals · 2025-07-24 | Vyvgart Hytrulo | $27 |
| Amgen | Meals · 2025-07-09 | Tepezza | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $5,637
| Amgen | Tepezza | $4,548 | 6 payments
|
| DENTSPLY Canada | Mis | $978 | 3 payments
|
| Abbvie | Botox | $92 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $19 | 1 payment
|
2023: $6,320
| Horizon Therapeutics plc | Tepezza | $6,258 | 12 payments
|
| Biotissue Holdings | Prokera | $24 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $23 | 1 payment
|
| Katalyst Surgical | None | $15 | 1 payment
|
2022: $706
| Horizon Therapeutics plc | Tepezza | $191 | 4 payments
|
| Axogen | Avance Nerve Graft | $171 | 1 payment
|
| Abbvie | Botox | $134 | 1 payment
|
| Johnson & Johnson Surgical Vision | Catalys System | $123 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $88 | 1 payment
|
2021: $494
| Horizon Therapeutics plc | Tepezza | $259 | 4 payments
|
| Tissuetech | Prokera | $129 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $106 | 1 payment
|
2020: $355
| Allergan | Ozurdex | $180 | 2 payments
|
| Novartis Pharmaceuticals | Beovu | $115 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $41 | 1 payment
|
| Medtronic USA | Midas Rex | $19 | 1 payment
|
2019: $1,100
| Novartis Pharmaceuticals | Durezol | $238 | 2 payments
|
| Allergan | Botox Cosmetic | $231 | 2 payments
|
| Genentech USA | Erivedge | $180 | 2 payments
|
| Mallinckrodt Enterprises | Acthar | $144 | 2 payments
|
| Alcon Vision | Acrysof | $103 | 1 payment
|
| Quidel | Eye Health | $93 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Symfony Iol | $88 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Retisert | $22 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 81.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1982967949
- Licence
- FL ME135518Florida ME135518: Active
- Trained
- University of California, Davis School of Medicine, 2014
- Group
- University of Miami
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207WX0200X (207WX0200X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-06-24
- NPI last updated
- 2026-07-31
- NPI record certified
- 2026-07-31
This is when the NPI record was last certified, not a medical board exam.